Ptc Therapeutics
Biopharmaceutical
Based in NJ
AI Overview
With $1.3M in lobbying spend across 26 quarterly filings, Ptc Therapeutics is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2019 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $50K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Ptc Therapeutics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Drug development, review and pricing related issues.
Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and PTC Therapeutics specifically.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.